Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference0.8%
- Check43 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check65 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check72 days agoChange DetectedA new Phase I-II study on Niraparib in combination with Cabozantinib for advanced urothelial cancer has been added, with updates scheduled for December 2024, while a previous study with similar details has been removed.SummaryDifference1%
Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.